Safety of meloxicam: A global analysis of clinical trials - Reply

被引:0
|
作者
Distel, M
Bluhmki, E
Muller, C
Fries, JF
机构
[1] BOEHRINGER INGELHEIM KG,DEPT BIOSTAT,INGELHEIM,GERMANY
[2] BOEHRINGER INGELHEIM KG,DEPT DATA MANAGEMENT,INGELHEIM,GERMANY
[3] STANFORD UNIV,SCH MED,DEPT RHEUMATOL & IMMUNOL,PALO ALTO,CA 94304
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1997年 / 36卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:818 / 819
页数:2
相关论文
共 50 条
  • [21] Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Sandborn, William J.
    Panaccione, Remo
    Robinson, Anne M.
    Lau, Winnie
    Li, Ju
    Cardoso, Alexandra T.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1308 - 1319
  • [22] Safety of Adalimumab in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Rutgeerts, Paul
    Sandborn, William J.
    Rutgeerts, Paul J.
    Hanauer, Stephen B.
    Reinisch, Walter
    Pollack, Paul F.
    Kent, Jeffrey D.
    Cardoso, Alexandra T.
    Lau, Winnie
    GASTROENTEROLOGY, 2009, 136 (05) : A651 - A651
  • [23] Analysis of Drug Safety Data From Clinical Trials
    Andrzej Czarnecki
    Katarzyna Zalewska
    Drug information journal : DIJ / Drug Information Association, 2002, 36 (1): : 157 - 162
  • [24] ANALYSIS OF SAFETY OF ATORVASTATIN IN ASIAN PATIENTS IN CLINICAL TRIALS
    Chan, Juliana
    Bao, Weihang
    Fayyad, Rana
    Laskey, Rachel
    Chan, Juliana
    HEART, 2012, 98 : E316 - E316
  • [25] Analysis of drug safety data from clinical trials
    Czarnecki, A
    Zalewska, K
    DRUG INFORMATION JOURNAL, 2002, 36 (01): : 157 - 162
  • [26] Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases
    Zhang, Huan
    Yu, Cheng
    Cheng, Yuanling
    Chen, Zhi
    Chen, Min
    He, Wangan
    Jin, Zhigang
    Cai, Shaoqian
    Yu, Lijuan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1863 - 1877
  • [27] Long-term safety of adalimumab for psoriasis: An analysis of all adalimumab exposure in all global clinical trials
    Leonardi, Craig
    Papp, Kim
    Rozzo, Stephen
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB132 - AB132
  • [28] Long-term safety of adalimumab for psoriasis: an analysis of all adalimumab exposure in all global clinical trials
    Leonardi, C.
    Papp, K.
    Asahina, A.
    Gu, Y.
    Rozzo, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 26 - 26
  • [29] Clinical trials and a meta-analysis of the effects of vitamins - Reply
    Bleys, Joachim
    Miller, Edgar R.
    Appel, Lawrence J.
    Guallar, Eliseo
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (05): : 1435 - 1436
  • [30] Intention-to-treat analysis and the goals of clinical trials - Reply
    Sheiner, LB
    Rubin, DB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 688 - 689